121 related articles for article (PubMed ID: 32515008)
1. High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population-based study.
Larsson K; Mattsson M; Ebrahim F; Glimelius I; Höglund M
Br J Haematol; 2020 Aug; 190(4):e245-e248. PubMed ID: 32515008
[No Abstract] [Full Text] [Related]
2. Increasing prevalence of chronic lymphocytic leukemia with an estimated future rise: A nationwide population-based study.
Mattsson M; Sandin F; Kimby E; Höglund M; Glimelius I
Am J Hematol; 2020 Feb; 95(2):E36-E38. PubMed ID: 31725930
[No Abstract] [Full Text] [Related]
3. Chronic lymphocytic leukaemia is a risk factor for venous thromboembolism.
Whittle AM; Allsup DJ; Bailey JR
Leuk Res; 2011 Mar; 35(3):419-21. PubMed ID: 21156322
[TBL] [Abstract][Full Text] [Related]
4. Trends in the incidence of leukaemia in Poland, 1963-90: an epidemiologic study.
Kwiatkowski A
Eur J Cancer Prev; 1994 May; 3(3):277-83. PubMed ID: 8061593
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
[TBL] [Abstract][Full Text] [Related]
6. Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.
Stilgenbauer S; Eichhorst B; Schetelig J; Coutre S; Seymour JF; Munir T; Puvvada SD; Wendtner CM; Roberts AW; Jurczak W; Mulligan SP; Böttcher S; Mobasher M; Zhu M; Desai M; Chyla B; Verdugo M; Enschede SH; Cerri E; Humerickhouse R; Gordon G; Hallek M; Wierda WG
Lancet Oncol; 2016 Jun; 17(6):768-778. PubMed ID: 27178240
[TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic leukemia in the elderly population.
Rai KR
Clin Geriatr Med; 1997 May; 13(2):245-9. PubMed ID: 9115449
[TBL] [Abstract][Full Text] [Related]
8. B-chronic lymphocytic leukaemia in Latvia: epidemiological aspects.
Yavorkovsky LI; Terebkova ZF; Nikulshin SV; Yavorkovsky LL
Eur J Haematol; 1993 Oct; 51(4):214-7. PubMed ID: 8243610
[TBL] [Abstract][Full Text] [Related]
9. National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953-2012: a systematic analysis of population-based data.
Lenartova A; Johannesen TB; Tjønnfjord GE
Cancer Med; 2016 Dec; 5(12):3588-3595. PubMed ID: 27925456
[TBL] [Abstract][Full Text] [Related]
10. Incidence rates of chronic lymphocytic leukemia in US states are associated with residential radon levels.
Schwartz GG; Klug MG
Future Oncol; 2016 Jan; 12(2):165-74. PubMed ID: 26515766
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic leukemia in Brazil: A retrospective analysis of 1903 cases.
Gonçalves MV; Rodrigues CA; Lorand Metze IGH; Lacerda MP; de Lourdes Lopes Ferrari Chauffaille M; Azevedo A; Machado C; Chiattone CS; Fortier S; Perobelli L; Ikoma MRV; Clementino N; Hamerschlak N; Sthel VM; Ommati LVM; de Farias DLC; Duarte FB; Buccheri V; de Azambuja AP; de Almeida DR; Figueiredo VLP; Yamamoto M
Am J Hematol; 2017 Aug; 92(8):E171-E173. PubMed ID: 28474845
[No Abstract] [Full Text] [Related]
12. Epidemiology of chronic lymphocytic leukaemia in an Irish subpopulation with total case ascertainment: an additional tool for health economic planning.
Waldron C; O'Brien D; Brophy S; Perera K; Crotty GM; Dunlea E; Walsh A; Connolly M; Clifford R; O'Leary H; Khan A; Lee G; Atkinson E; Le G; Gillett A; Bacon CL; McElligott AM; Quinn F; Vandenberghe E
Br J Haematol; 2022 Mar; 196(5):e47-e49. PubMed ID: 34783371
[No Abstract] [Full Text] [Related]
13. The effectiveness of ibrutinib in chronic lymphocytic leukaemia: a nationwide, population-based study in the Netherlands.
van der Straten L; Levin MD; Visser O; Blijlevens NMA; Cornelissen JJ; Doorduijn JK; Kater AP; Dinmohamed AG
Br J Haematol; 2020 Mar; 188(6):e109-e112. PubMed ID: 31991479
[No Abstract] [Full Text] [Related]
14. Challenges in assessing the real incidence of chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain.
Solans M; Osca-Gelis G; Comas R; Roncero JM; Gallardo D; Marcos-Gragera R; Saez M
Cancer Causes Control; 2018 Mar; 29(3):379-382. PubMed ID: 29383469
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease in patients with chronic lymphocytic leukemia: A Swedish nationwide register study with matched comparators.
Larsson K; Söderling J; Höglund M; Glimelius I; Mattsson M
Am J Hematol; 2022 Jul; 97(7):E255-E257. PubMed ID: 35384027
[No Abstract] [Full Text] [Related]
16. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
[TBL] [Abstract][Full Text] [Related]
17. Incidence of cutaneous squamous cell carcinoma in a New Zealand population of chronic lymphocytic leukaemia patients.
Hock BD; McIntosh ND; McKenzie JL; Pearson JF; Simcock JW; MacPherson SA
Intern Med J; 2016 Dec; 46(12):1414-1421. PubMed ID: 27664975
[TBL] [Abstract][Full Text] [Related]
18. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
20. Patterns of occurrence of the leukaemias.
Groves FD; Linet MS; Devesa SS
Eur J Cancer; 1995 Jun; 31A(6):941-9. PubMed ID: 7646927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
